Epidiolex maker GW reports record quarterly revenue of $137 million

MJBizDaily
By Alfredo PascualNov 4, 2020, 1:43 pm228 pts
United Kingdom-based GW Pharmaceuticals posted higher revenue in the quarter ended Sept. 30, largely driven by sales of its cannabidiol medicine Epidiolex in the United States. GW’s total revenue for the third quarter reached $137.1 million, about 16% more than the previous quarter’s $121.3 million. U.S.…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

TerrAscend Renews, Replenishes $10M Share Repurchase Program 79

FLUENT Partners With Connected Cannabis at its New Cultivation Facility in New York 79

From ‘sin taxes’ to potency pricing: Modern approaches to excise tax policy 78

Ohio Sold $700M In Adult-Use Cannabis During First Year of Sales 78

Alaska Psychedelics Campaign Cleared To Collect Signatures For 2026 Legalization Ballot Initiative 77

A year into adult-use cannabis sales, Ohio now allows pre-rolls 74

Tilray Is a Dangerous Stock 44

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.